Anders Andersen
Impact in
- Transplantation top 5%
-
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
- Cardiac Valve Diseases and Treatments 5
- Surgery 11
- Co-authors
- Lars Slørdal (8 shared papers)David J. Warren (7 shared papers)Harald Olsen (8 shared papers)David J. Warren (6 shared papers)Kirsten Sundby Hall (3 shared papers)J. Ladefoged (1 shared paper)Knut Rasmussen (4 shared papers)Lars Mørkrid (1 shared paper)
- Journals
- Therapeutic Drug Monitoring (10 papers)Cancer Chemotherapy and Pharmacology (9 papers)Life Sciences (2 papers)The Pharmacogenomics Journal (2 papers)American Heart Journal (2 papers)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Anders Andersen
66 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Transplantation 42
- Oncology 197
- Cardiology and Cardiovascular Medicine 158
- Hematology 80
- Pediatrics, Perinatology and Child Health 115
Countries citing papers authored by Anders Andersen
This map shows the geographic impact of Anders Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Andersen more than expected).
Fields of papers citing papers by Anders Andersen
This network shows the impact of papers produced by Anders Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Andersen. The network helps show where Anders Andersen may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Andersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 112 | |
| 2 | 2016 | 106 | |
| 3 | 1999 | 69 | |
| 4 | Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy. | 1995 | 68 |
| 5 | 2006 | 59 | |
| 6 | 2004 | 54 | |
| 7 | 1993 | 54 | |
| 8 | 1967 | 53 | |
| 9 | 1970 | 53 | |
| 10 | 2019 | 45 | |
| 11 | 2015 | 37 | |
| 12 | 2007 | 36 | |
| 13 | 2000 | 32 | |
| 14 | 2010 | 30 | |
| 15 | 1999 | 25 | |
| 16 | 1999 | 23 | |
| 17 | 1996 | 23 | |
| 18 | 1977 | 21 | |
| 19 | 1996 | 20 | |
| 20 | 2018 | 19 |
About Anders Andersen
Anders Andersen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Public Health, Environmental and Occupational Health, Molecular Biology and Oncology, having authored 68 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Cardiac Valve Diseases and Treatments (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Transplantation (42 citations), Oncology (197 citations), Cardiology and Cardiovascular Medicine (158 citations), Hematology (80 citations) and Pediatrics, Perinatology and Child Health (115 citations). Anders Andersen has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Lars Slørdal, David J. Warren, Harald Olsen, David J. Warren, Kirsten Sundby Hall, J. Ladefoged, Knut Rasmussen, Lars Mørkrid, Ulf E. Kongsgaard and Karl Erik Giercksky. Their work appears in journals such as Therapeutic Drug Monitoring, Cancer Chemotherapy and Pharmacology, Life Sciences, The Pharmacogenomics Journal and American Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.